Pasca, Samantha
 Distribuzione geografica
Continente #
NA - Nord America 154
AS - Asia 44
Continente sconosciuto - Info sul continente non disponibili 31
EU - Europa 22
SA - Sud America 2
AF - Africa 1
Totale 254
Nazione #
US - Stati Uniti d'America 149
SG - Singapore 15
IT - Italia 13
CN - Cina 12
HK - Hong Kong 5
MX - Messico 4
BD - Bangladesh 3
IN - India 3
BR - Brasile 2
DE - Germania 2
FI - Finlandia 2
SE - Svezia 2
VN - Vietnam 2
CA - Canada 1
GB - Regno Unito 1
ID - Indonesia 1
LT - Lituania 1
LV - Lettonia 1
MM - Myanmar 1
PH - Filippine 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 223
Città #
St Louis 30
Council Bluffs 18
San Jose 16
Singapore 13
Columbus 11
Ashburn 9
Trento 8
Phoenix 7
Boardman 5
Hong Kong 5
Beijing 3
Fort Worth 3
Mexico City 3
New York 3
Portland 3
Santa Clara 3
Buffalo 2
Chicago 2
Conway 2
Helsinki 2
Jacksonville 2
Kirkland 2
Milan 2
Newport 2
Salem 2
Shenzhen 2
Allen Park 1
Bakersfield 1
Bitonto 1
Bắc Giang 1
Chandigarh 1
Cincinnati 1
Cornwall-on-Hudson 1
Culiacán 1
Dallas 1
Danvers 1
Dasmariñas 1
Dehradun 1
Frankfurt am Main 1
Ho Chi Minh City 1
Khon Kaen 1
Kudus 1
Lancaster 1
Lansdowne 1
Las Vegas 1
Lithonia 1
London 1
Long Beach 1
Los Angeles 1
Los Fresnos 1
Maywood 1
Miano 1
Minneapolis 1
Miāni 1
Natal 1
Norfolk 1
North Kansas City 1
Palermo 1
Pasadena 1
Pretoria 1
Regina 1
Reutlingen 1
Riga 1
Rio de Janeiro 1
San Francisco 1
Totale 199
Nome #
Specific serum biomarkers to assess the bone health in hemophilia A carriers: the CAR.BONE Study 32
Bleeding Episodes in Patients With Haemophilia B Receiving Prophylactic Factor IX Treatment: A Systematic Review and Meta-Analysis 30
Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect 26
Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia 25
D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE registry 23
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients 22
Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding 21
Bilirubin color interference on prothrombin time and activated partial thromboplastin time tests assessed in patients with liver disease 19
Specific serum biomarkers to assess the bone health in a group of hemophilia A carriers: data from the CAR.BONE Study 18
Gender difference among blood donors: should laboratory ranges be changed? 14
Coagulation and oxidative stress plasmatic levels in a type 2 diabetes population 11
Correction to: The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison (Journal of Thrombosis and Thrombolysis, (2022), 54, 4, (593-596), 10.1007/s11239-022-02700-x) 5
The effective use of platelet-rich plasma (PRP) in treating a severe traumatic knee injury in a child with hemophilia A: PRP in the treatment of severe injury in hemophilia child 4
Factor II and Factor V Deficiencies: Current Management, Care Gaps and Call to Action for Therapeutic Advances 4
Totale 254
Categoria #
all - tutte 896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 896


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026153 0 0 0 0 0 0 0 0 12 118 13 10
2026/2027101 29 48 24 0 0 0 0 0 0 0 0 0
Totale 254